The Albanian Government Has Drafted a Medical Cannabis Law

Following the results of the referendum proposed by the Albanian Prime Minister, Albania has decided to open the production of medical cannabis in the territory, for the moment, only for export.

And the least we can say is that Albania is wasting no time. The medical cannabis law and the conditions for obtaining licenses relating to the production of cannabis have already been drafted—this just 4 months after the end of the referendum.

To keep up with this story as it unfolds, download our free cannabis news app.

Albanian Government’s Legal Aims

The legal initiative aims to regulate and control the cultivation, processing, and export of the Cannabis plant and the production of its by-products, intended for medical and industrial purposes.

For the implementation of the law, the National Agency for the Control and Monitoring of the Cultivation and Processing of the Cannabis Plant has been created and will depend on the Albanian Ministry of Health. The agency is responsible for controlling and monitoring the process at all levels, from seeds, planting, harvesting, drying and the final destination of the cannabis.

The Albanian government will approve each company’s license based on certain selection criteria and procedures organized by the National Cannabis Agency. The decision to provide a company with a license for the cultivation of cannabis is proposed by the Minister of Health, in this case by Minister Ogerta Manastirliu.

Restriction: No More than 150 Hectares

The law sets a limit on the maximum area of ​​land that can be cultivated with cannabis in Albania. Specifically, the total area authorized for the cultivation of the Cannabis plant for medical purposes cannot exceed 150 hectares nationwide.

In addition, the area of ​​the activity license unit for medical purposes cannot be less than 5 hectares or more than 10 hectares. This restriction is expected to spark a tug of war between companies for licenses.

Conditions for Obtaining an Albanian Medical Cannabis License

The law sets strict criteria for obtaining a license. In practice, no Albanian company meets these conditions, since the first criterion is that the company must have experience in the cultivation, production, processing, circulation and administration of the cannabis plant.

The company or shareholder holding 51% of the shares of the company must be engaged in the production of products derived from the cannabis plant in one of the 38 countries that are part of the Organization for Economic Co-operation and Development. The entity must have at least a GMP certificate issued by the European Medicines Agency and the American Food and Drug Administration. In addition, the company must have a capital of at least 100,000,000 Albanian leks (825,000 €).

Albanian Medical Cannabis License Applications

Interested companies in Albania should also submit their business development plan, cultivation model, and cultivation goal, as well as the minimum and maximum area of ​​the development unit. They must present a treatment plan for the premises for the drying, cutting and storage of cannabis.

The Albanian government’s security plan for the cannabis cultivation and processing area defines elements such as fencing, security with cameras, and physical security for 24 hours.

Among the criteria for applying for Albanian license are the self-declaration of the employment of at least fifteen people, the self-declaration of the will to conclude agreements with the responsible structure of the ministry in charge of order public and security to ensure access for inspection and self-declaration that it will begin to exercise within 12 months of obtaining the license.

Entities will also have to agree to pay, after the third year, an annual fee equal to 1.5% of annual turnover, but in any case, not less than 10,000,000 Albanian leks (€82,500).

—

(Featured image by Terrance Barksdale via Pexels)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published by Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions, or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.